Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: A viewpoint in the era of preoperative treatment

Annals of Surgery

Volumn 251, Issue 3, 2010, Pages 428-435

  Park, Sook Ryun ^a   Kim, Min Ju ^a   Ryu, Keun Won ^a   Lee, Jun Ho ^a   Lee, Jong Seok ^a   Nam, Byung Ho ^a   Choi, Il Ju ^a   Kim, Young Woo ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH CARCINOMA; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; PROGNOSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 77649159783     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181ca69a7     Document Type: Article

References (40)

1. Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305-315.
2. Shin HR, Jung KW, Won YJ, et al. National cancer incidence for the year 2002 in Korea. Cancer Res Treat. 2007;39:139-149.
3. De Vita F, Giuliani F, Galizia G, et al. Neo-adjuvant and adjuvant chemotherapy of gastric cancer. Ann Oncol. 2007;18(suppl 6):vi120-vi123.
4. Dicken BJ, Bigam DL, Cass C, et al. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27-39.
5. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.
6. Boige V, Pignon J, Saint-Aubert B, et al. Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. Proc Am Soc Clin Oncol. 2007;25:200s (Abstract 4510).
7. Kim JP, Lee JH, Kim SJ, et al. Clinicopathologic characteristics and prognostic factors in 10,783 patients with gastric cancer. Gastric Cancer. 1998; 1:125-133.
8. Yokota T, Ishiyama S, Saito T, et al. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol. 2004;39:380-384.
9. Kwee RM, Kwee TC. Imaging in local staging of gastric cancer: a systematic review. J Clin Oncol. 2007;25:2107-2116.
10. Wang JY, Hsieh JS, Huang YS, et al. Endoscopic ultrasonography for preoperative locoregional staging and assessment of resectability in gastric cancer. Clin Imaging. 1998;22:355-359.
11. Mancino G, Bozzetti F, Schicchi A, et al. Preoperative endoscopic ultra-sonography in patients with gastric cancer. Tumori. 2000;86:139-141.
12. Xi WD, Zhao C, Ren GS. Endoscopic ultrasonography in preoperative staging of gastric cancer: determination of tumor invasion depth, nodal involvement and surgical resectability. World J Gastroenterol. 2003;9:254-257.
13. Willis S, Truong S, Gribnitz S, et al. Endoscopic ultrasonography in the preoperative staging of gastric cancer: accuracy and impact on surgical therapy. Surg Endosc. 2000;14:951-954.
14. Bhandari S, Shim CS, Kim JH, et al. Usefulness of three-dimensional, multidetector row CT (virtual gastroscopy and multiplanar reconstruction) in the evaluation of gastric cancer: a comparison with conventional endoscopy, EUS, and histopathology. Gastrointest Endosc. 2004;59:619-626.
15. Shimoyama S, Yasuda H, Hashimoto M, et al. Accuracy of linear-array EUS for preoperative staging of gastric cardia cancer. Gastrointest Endosc. 2004; 60:50-55.
16. Ganpathi IS, So JB, Ho KY. Endoscopic ultrasonography for gastric cancer: does it influence treatment? Surg Endosc. 2006;20:559-562.
17. D'Elia F, Zingarelli A, Palli D, et al. Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol. 2000;10:1877-1885.
18. Habermann CR, Weiss F, Riecken R, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology. 2004;230:465-471.
19. Takao M, Fukuda T, Iwanaga S, et al. Gastric cancer: evaluation of triphasic spiral CT and radiologic-pathologic correlation. J Comput Assist Tomogr. 1998;22:288-294.
20. Hundt W, Braunschweig R, Reiser M. Assessment of gastric cancer: value of breathhold technique and two-phase spiral CT. Eur Radiol. 1999;9:68-72.
21. Shimizu K, Ito K, Matsunaga N, et al. Diagnosis of gastric cancer with MDCT using the water-filling method and multiplanar reconstruction: CT-histologic correlation. AJR Am J Roentgenol. 2005;185:1152-1158.
22. Chen CY, Hsu JS, Wu DC, et al. Gastric cancer: preoperative local staging with 3D multi-detector row CT-correlation with surgical and histopatho-logic results. Radiology. 2007;242:472-482.
23. Hur J, Park MS, Lee JH, et al. Diagnostic accuracy of multidetector row computed tomography in T and N staging of gastric cancer with histopatho-logic correlation. J Comput Assist Tomogr. 2006;30:372-377.
24. Sobin LH, Wittekind C. TNM Classification of Malignant Tumors. 6th ed. New York, NY: Wiley-Liss Inc; 2002
25. Japanese Gastric Cancer Association. Japanese classification of gastric car-cinoma-2nd English edition. Gastric Cancer. 1998;1:10-24.
26. Roder JD, Bottcher K, Busch R, et al; German Gastric Cancer Study Group. Classification of regional lymph node metastasis from gastric carcinoma. Cancer. 1998;82:621-631.
27. Yoo CH, Noh SH, Kim YI, et al. Comparison of prognostic significance of nodal staging between old (4th edition) and new (5th edition) UICC TNM classification for gastric carcinoma. World J Surg. 1999;23:492-497; discussion 497-498.
28. Ichikawa D, Kurioka H, Ueshima Y, et al. Prognostic value of lymph node staging in gastric cancer. Hepatogastroenterology. 2003;50:301-304.
29. Kato M, Saji S, Kawaguchi Y, et al. A comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage in gastric carcinoma. Hepatogastroenterology. 1999;46:3281-3286.
30. Klein Kranenbarg E, Hermans J, van Krieken JH, et al. Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer. 2001;84:64-71.
31. Hermanek P. The superiority of the new International Union against cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma. Cancer. 2000;88:1763-1765.
32. Ichikura T, Tomimatsu S, Uefuji K, et al. Evaluation of the new American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer. 1999;86:553-558.
33. Sayegh ME, Sano T, Dexter S, et al. TNM and Japanese staging systems for gastric cancer: how do they coexist? Gastric Cancer. 2004;7:140-148.
34. Aurello P, D'Angelo F, Rossi S, et al. Classification of lymph node metas-tases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg. 2007;73:359-366.
35. Fujii K, Isozaki H, Okajima K, et al. Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system. Br J Surg. 1999;86:685-689.
36. Hayashi H, Ochiai T, Suzuki T, et al. Superiority of a new UICC-TNM staging system for gastric carcinoma. Surgery. 2000;127:129-135.
37. Kim SK, Kang KW, Lee JS, et al. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging. 2006;33:148-155.
38. Kelsen D, Karpeh M, Schwartz G, et al. Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol. 1996;14:1818-1828.
39. Ajani JA, Mansfield PF, Janjan N, et al. Multi-institutional trial of preoper-ative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol. 2004;22:2774-2780.
40. Ajani JA, Mansfield PF, Crane CH, et al. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol. 2005;23:1237-1244.